Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients

NCT04721873 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Colitis, Ulcerative
Obesity

Interventions

DRUG: Phentermine-Topiramate
DRUG: Placebo

Sponsor

University of California, San Diego